BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 17507482)

  • 1. A naturally occurring splice variant of CXCL12/stromal cell-derived factor 1 is a potent human immunodeficiency virus type 1 inhibitor with weak chemotaxis and cell survival activities.
    Altenburg JD; Broxmeyer HE; Jin Q; Cooper S; Basu S; Alkhatib G
    J Virol; 2007 Aug; 81(15):8140-8. PubMed ID: 17507482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The potent anti-HIV activity of CXCL12gamma correlates with efficient CXCR4 binding and internalization.
    Altenburg JD; Jin Q; Alkhatib B; Alkhatib G
    J Virol; 2010 Mar; 84(5):2563-72. PubMed ID: 20015992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiogenic effects of stromal cell-derived factor-1 (SDF-1/CXCL12) variants in vitro and the in vivo expressions of CXCL12 variants and CXCR4 in human critical leg ischemia.
    Ho TK; Tsui J; Xu S; Leoni P; Abraham DJ; Baker DM
    J Vasc Surg; 2010 Mar; 51(3):689-99. PubMed ID: 20206813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SDF-1/CXCL12 enhances survival and chemotaxis of murine embryonic stem cells and production of primitive and definitive hematopoietic progenitor cells.
    Guo Y; Hangoc G; Bian H; Pelus LM; Broxmeyer HE
    Stem Cells; 2005 Oct; 23(9):1324-32. PubMed ID: 16210409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CXCR4 and CCR5 on human thymocytes: biological function and role in HIV-1 infection.
    Zaitseva MB; Lee S; Rabin RL; Tiffany HL; Farber JM; Peden KW; Murphy PM; Golding H
    J Immunol; 1998 Sep; 161(6):3103-13. PubMed ID: 9743377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CXCL14 is a natural inhibitor of the CXCL12-CXCR4 signaling axis.
    Tanegashima K; Suzuki K; Nakayama Y; Tsuji K; Shigenaga A; Otaka A; Hara T
    FEBS Lett; 2013 Jun; 587(12):1731-5. PubMed ID: 23669361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of human immunodeficiency virus replication by a dual CCR5/CXCR4 antagonist.
    Princen K; Hatse S; Vermeire K; Aquaro S; De Clercq E; Gerlach LO; Rosenkilde M; Schwartz TW; Skerlj R; Bridger G; Schols D
    J Virol; 2004 Dec; 78(23):12996-3006. PubMed ID: 15542651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stromal cell-derived factor-1 binding to its chemokine receptor CXCR4 on precursor cells promotes the chemotactic recruitment, development and survival of human osteoclasts.
    Wright LM; Maloney W; Yu X; Kindle L; Collin-Osdoby P; Osdoby P
    Bone; 2005 May; 36(5):840-53. PubMed ID: 15794931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced functional response to CXCL12/SDF-1 through retroviral overexpression of CXCR4 on M07e cells: implications for hematopoietic stem cell transplantation.
    Porecha NK; English K; Hangoc G; Broxmeyer HE; Christopherson KW
    Stem Cells Dev; 2006 Jun; 15(3):325-33. PubMed ID: 16846371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluorescent CXCL12AF647 as a novel probe for nonradioactive CXCL12/CXCR4 cellular interaction studies.
    Hatse S; Princen K; Liekens S; Vermeire K; De Clercq E; Schols D
    Cytometry A; 2004 Oct; 61(2):178-88. PubMed ID: 15382150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CXCL12γ isoform is expressed on endothelial and dendritic cells in rheumatoid arthritis synovium and regulates T cell activation.
    Santiago B; Izquierdo E; Rueda P; Del Rey MJ; Criado G; Usategui A; Arenzana-Seisdedos F; Pablos JL
    Arthritis Rheum; 2012 Feb; 64(2):409-17. PubMed ID: 21953583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heparan sulfate differentially controls CXCL12α- and CXCL12γ-mediated cell migration through differential presentation to their receptor CXCR4.
    Connell BJ; Sadir R; Baleux F; Laguri C; Kleman JP; Luo L; Arenzana-Seisdedos F; Lortat-Jacob H
    Sci Signal; 2016 Nov; 9(452):ra107. PubMed ID: 27803285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutralising properties of peptides derived from CXCR4 extracellular loops towards CXCL12 binding and HIV-1 infection.
    Chevigné A; Fievez V; Szpakowska M; Fischer A; Counson M; Plesséria JM; Schmit JC; Deroo S
    Biochim Biophys Acta; 2014 May; 1843(5):1031-41. PubMed ID: 24480462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The two human CXCR4 isoforms display different HIV receptor activities: consequences for the emergence of X4 strains.
    Duquenne C; Psomas C; Gimenez S; Guigues A; Carles MJ; Barbuat C; Lavigne JP; Sotto A; Reynes J; Guglielmi P; Mettling C; François V; Corbeau P
    J Immunol; 2014 Oct; 193(8):4188-94. PubMed ID: 25230750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [CXCL12α and CXCL12β stimulate the migration of cultured LX-2 hepatic stellate cells].
    Yuan X; Xiao T; Dai F; Yu Y; Lou J
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 Mar; 31(3):293-6. PubMed ID: 25744829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of the CXC chemokine receptor 4/stromal cell-derived factor 1 pathway enhances myocardial neovascularization, cardiomyocyte survival, and functional recovery after myocardial infarction.
    Bonaros N; Sondermeijer H; Wiedemann D; Schlechta B; Schachner T; Schuster M; Seki T; Martens TP; Itescu S; Kocher AA
    J Thorac Cardiovasc Surg; 2011 Sep; 142(3):687-96, 696.e1-2. PubMed ID: 21388641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of stromal-derived factor-1 in the hematopoietic-supporting activity of human mesenchymal stem cells.
    Van Overstraeten-Schlögel N; Beguin Y; Gothot A
    Eur J Haematol; 2006 Jun; 76(6):488-93. PubMed ID: 16494621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CXCL14 antagonizes the CXCL12-CXCR4 signaling axis.
    Hara T; Tanegashima K
    Biomol Concepts; 2014 May; 5(2):167-73. PubMed ID: 25372750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Marked structural and functional heterogeneity in CXCR4: separation of HIV-1 and SDF-1alpha responses.
    Sloane AJ; Raso V; Dimitrov DS; Xiao X; Deo S; Muljadi N; Restuccia D; Turville S; Kearney C; Broder CC; Zoellner H; Cunningham AL; Bendall L; Lynch GW
    Immunol Cell Biol; 2005 Apr; 83(2):129-43. PubMed ID: 15748209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AMD3465, a monomacrocyclic CXCR4 antagonist and potent HIV entry inhibitor.
    Hatse S; Princen K; De Clercq E; Rosenkilde MM; Schwartz TW; Hernandez-Abad PE; Skerlj RT; Bridger GJ; Schols D
    Biochem Pharmacol; 2005 Sep; 70(5):752-61. PubMed ID: 16011832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.